Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe, Tosoh Bioscience Cross-License Nucleic Acid Testing IP

NEW YORK, Dec. 9 - Gen-Probe and the Tosoh Bioscience unit of Tokyo-based Tosoh Corp. said today that they have cross-licensed intellectual property covering certain nucleic acid testing technologies.

Tosoh will receive non-exclusive rights to Gen-Probe's transcription-mediated amplification (TMA) and ribosomal RNA technologies in exchange for two payments in 2004. Tosoh will also pay Gen-Probe royalties on worldwide sales of products based on the licensed Gen-Probe technologies.
Gen-Probe will gain access, in exchange for royalties, to Tosoh's patented TRC (t
ranscription reverse-transcription concerted) amplification and INAF (intercalation activating fluorescence) detection technologies for use with real-time TMA.

The licenses are effective Jan. 1, 2004.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.